UK DRI joins CaSE

The Campaign for Science and Engineering (CaSE) are excited to welcome the UK Dementia Research Institute (UK DRI) to its membership.

CaSE represents over 115 scientific organisations including businesses, universities, professional bodies, and research charities as well as individual scientists and engineers, working in partnership to deliver a clear expert voice on decisions about science and engineering.

Commenting on the announcement, Professor Sarah Main, Executive Director of CaSE, said:

“We are delighted that the UK Dementia Research Institute (UK DRI) have joined CaSE. The Institute is at the forefront of neurodegenerative research in the UK. Their experience and perspective on tackling complex disease through research will be a valuable asset for the growing CaSE membership community. The diversity of our membership from across the research and innovation sector is a source of pride for CaSE, I am thrilled that UK DRI are adding to that richness.

“The ground-breaking research conducted by UK DRI, into a range of neurodegenerative disorders that cause dementia, has the potential to transform lives across the country. We look forward to working with them over the coming years, to continue putting science at the heart of the UK’s future.”

Dr Adrian Ivinson, Co-Director (COO) of the UK Dementia Research Institute, added:

“I am delighted that the UK Dementia Research Institute (UK DRI) is becoming a member of CaSE. Since our inception in 2017, we have assembled a critical mass of 800+ researchers working to fill the knowledge gap in dementia and find new treatments for the diseases that cause it.

“As an organisation, we have championed multidisciplinary, intensely collaborative discovery science from the start. I am delighted that we will now be able to work as members of CaSE to share our expertise in the field of neurodegeneration, continue to advocate for collaborative, inclusive research, and build the right environment for our scientists – and all UK science – to thrive.”

About UK DRI

Founded in 2017 by the Medical Research Council (MRC), Alzheimer’s Society and Alzheimer’s Research UK, the UK Dementia Research Institute (UK DRI) is the UK’s national institute dedicated to stopping dementia in its tracks. Its mission is to understand the drivers of neurodegenerative disease, fill the dementia knowledge gap, and transform that knowledge into real-world tools, diagnostics and treatments.

Currently, there are no effective therapeutics for dementia approved for use in the UK. The UK DRI is leading the UK’s dementia research efforts and tackling the huge challenge of the condition, which affects nearly 1 million people in the UK, and is consistently the leading cause of death in England and Wales.

The UK DRI is a multidisciplinary institute studying diseases including Alzheimer’s disease, motor neuron disease (MND), Parkinson’s disease, frontotemporal dementia, vascular dementia, Huntington’s disease and beyond.